ILMA Compoundings - May 2021 - 15

represent a small fraction of the manufactured substances
facing regulatory exposure.
The EU market has functioned with very similar fluidity
since its formation. Manufacturers and distributors have
not needed to track the potential downstream distribution
dynamics of their products. Once product ingredients are
qualified for the EU market, the supply chain dynamics
flow relatively unencumbered - except for member state
or local laws that are analogous to U.S. state laws like California Prop 65. Compliance with EU REACH has been
the main potential impediment, and once compliance is
established (and maintained), its commercial impact fades.
The EU market functions essentially without borders.
Brexit has disrupted that in ways that many players previously contemplated. With dynamics similar to the impact
that would occur if a U.S. state adopted its own TSCA-like
law that added a market eligibility requirement in competition with TSCA, EU manufacturers and distributors
face a labyrinth of scenarios that challenge their ability to
assure compliance with the new U.K. REACH requirements
after the grandfathering period ends. The opacity of trade
between U.K. companies and EU companies is now very
real, and so is the opportunity for U.K. REACH noncompliant shipments.
URGENT REEVALUATION NEEDED
The motivation for U.S. manufacturers to comply with
U.K. REACH is becoming acute. As was the consideration
with their election to self-register with EU REACH, U.S.
and other global manufacturers are finding self-registration
in the U.K. to be a more difficult evaluation than was
originally believed. One reason for this is that U.S. suppliers based prior thinking on direct sales (or their absence)
to entities in the U.K. There was no perceived need or
opportunity to track indirect sales to U.K. customers
by EU product manufacturers and distributors. Another
reason is that EU customers (product manufacturers and

their distributors) are now recognizing that the complexities of product distribution pose a risk of costly disruption
or penalty.
However, an opacity remains among downstream product
manufacturers and distributors concerning specific substances used in the formulations they make and sell into the
U.K. They are unaware of many substances included in their
purchased materials, due to upstream supplier confidentiality. Similarly, they remain reluctant to candidly reveal details
concerning their intended distribution to the U.K. The
consequence of these tendencies places increased pressure on
foreign substance manufacturers to proactively avoid decline
in EU sales by registering substances in the U.K. without
the hard numbers typically used for such decisions.
GRANDFATHERING
Companies that wish to preserve U.K. market eligibility
for substances registered in the EU must create an account
with U.K. REACH and submit a Downstream User Import
Notification (DUIN) based on an existing EU REACH
substance registration. This is required for substances per se
or in products or articles. This DUIN must be submitted by
Oct. 27 to qualify for grandfathering.
Company registration and submittal of a DUIN will
typically require assistance by an only representative in the
U.K. Several EU only representatives have opened and registered offices in the U.K., which enables a smooth and quick
company registration and DUIN submittal for customers
of those only representatives. Also, manufacturers that have
offices in the U.K. might qualify to submit the company
registration and DUIN through that entity or office.
Although this step imposes costs that might be unnecessary if the manufacturer ultimately chooses not to register
substances in the U.K., it offers a relatively inexpensive way
to preserve substance market eligibility in the U.K. until
the registration deadline, which can amount to an extension of up to six years, depending on the substance and
registration volume.
Eggenschwiler, an ILMA consultant, is an international
trade attorney and is principal consultant, global trade
and chemical regulation services, at the Redstone Group,
a Trinity Consultants company. He can be reached at
614-923-7472 or jeggenschwiler@redstonegrp.com.

15



ILMA Compoundings - May 2021

Table of Contents for the Digital Edition of ILMA Compoundings - May 2021

ILMA Compoundings - May 2021 - Cover1
ILMA Compoundings - May 2021 - Cover2
ILMA Compoundings - May 2021 - 1
ILMA Compoundings - May 2021 - 2
ILMA Compoundings - May 2021 - 3
ILMA Compoundings - May 2021 - 4
ILMA Compoundings - May 2021 - 5
ILMA Compoundings - May 2021 - 6
ILMA Compoundings - May 2021 - 7
ILMA Compoundings - May 2021 - 8
ILMA Compoundings - May 2021 - 9
ILMA Compoundings - May 2021 - 10
ILMA Compoundings - May 2021 - 11
ILMA Compoundings - May 2021 - 12
ILMA Compoundings - May 2021 - 13
ILMA Compoundings - May 2021 - 14
ILMA Compoundings - May 2021 - 15
ILMA Compoundings - May 2021 - 16
ILMA Compoundings - May 2021 - 17
ILMA Compoundings - May 2021 - 18
ILMA Compoundings - May 2021 - 19
ILMA Compoundings - May 2021 - 20
ILMA Compoundings - May 2021 - 21
ILMA Compoundings - May 2021 - 22
ILMA Compoundings - May 2021 - 23
ILMA Compoundings - May 2021 - 24
ILMA Compoundings - May 2021 - 25
ILMA Compoundings - May 2021 - 26
ILMA Compoundings - May 2021 - 27
ILMA Compoundings - May 2021 - 28
ILMA Compoundings - May 2021 - 29
ILMA Compoundings - May 2021 - 30
ILMA Compoundings - May 2021 - 31
ILMA Compoundings - May 2021 - 32
ILMA Compoundings - May 2021 - 33
ILMA Compoundings - May 2021 - 34
ILMA Compoundings - May 2021 - 35
ILMA Compoundings - May 2021 - 36
ILMA Compoundings - May 2021 - 37
ILMA Compoundings - May 2021 - 38
ILMA Compoundings - May 2021 - 39
ILMA Compoundings - May 2021 - 40
ILMA Compoundings - May 2021 - Cover3
ILMA Compoundings - May 2021 - Cover4
https://www.nxtbook.com/ygsreprints/ILMA/G127535ILMA_vol71_no7
https://www.nxtbook.com/ygsreprints/ILMA/G126213ILMA_vol71_no6
https://www.nxtbook.com/ygsreprints/ILMA/G125546_ILMA_vol71_no5
https://www.nxtbook.com/ygsreprints/ILMA/G124996_ILMA_vol71_no4
https://www.nxtbook.com/ygsreprints/ILMA/G123886_ILMA_vol71_no3
https://www.nxtbook.com/ygsreprints/ILMA/G123315_ILMA_vol71_no2
https://www.nxtbook.com/ygsreprints/ILMA/G122980_ILMA_vol71_no1
https://www.nxtbook.com/ygsreprints/ILMA/G121540_ILMA_vol70_no11
https://www.nxtbook.com/ygsreprints/ILMA/G120882_ILMA_vol70_no10
https://www.nxtbook.com/ygsreprints/ILMA/G120035_ILMA_vol70_no9
https://www.nxtbook.com/ygsreprints/ILMA/G121XXX_ILMA_vol70_no8
https://www.nxtbook.com/ygsreprints/ILMA/G120XXX_ILMA_vol70_no7
https://www.nxtbook.com/ygsreprints/ILMA/G119XXX_ILMA_vol70_no6
https://www.nxtbook.com/ygsreprints/ILMA/G118112_ILMA_vol70_no5
https://www.nxtbook.com/ygsreprints/ILMA/G117382_ILMA_vol70_no4
https://www.nxtbook.com/ygsreprints/ILMA/G116888_ILMA_vol70_no3
https://www.nxtbook.com/ygsreprints/ILMA/G115555_ILMA_vol70_no2
https://www.nxtbook.com/ygsreprints/ILMA/G114774_ILMA_vol70_no1
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no12
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no11
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no10
https://www.nxtbook.com/ygsreprints/ILMA/g109884_ILMA_vol69_no9
https://www.nxtbook.com/ygsreprints/ILMA/g109284_ILMA_vol69_no8
https://www.nxtbook.com/ygsreprints/ILMA/g108494_ILMA_vol69_no7
https://www.nxtbook.com/ygsreprints/ILMA/g107507_ILMA_vol69_no6
https://www.nxtbook.com/ygsreprints/ILMA/g106483_ILMA_vol69_no5
https://www.nxtbook.com/ygsreprints/ILMA/g105803_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/g104743_ILMA_vol69_no3
https://www.nxtbook.com/ygsreprints/ILMA/g103647_ILMA_vol69_no2
https://www.nxtbook.com/ygsreprints/ILMA/g102869_ILMA_vol69_no1
https://www.nxtbook.com/ygsreprints/ILMA/g101930_ILMA_vol68_no12
https://www.nxtbook.com/ygsreprints/ILMA/g100836_ILMA_vol68_no11
https://www.nxtbook.com/ygsreprints/ILMA/g99200_ILMA_vol68_no10
https://www.nxtbook.com/ygsreprints/ILMA/g98468_ILMA_vol68_no9
https://www.nxtbook.com/ygsreprints/ILMA/g97711_ILMA_vol68_no8
https://www.nxtbook.com/ygsreprints/ILMA/G96767ILMA_vol68_no7
https://www.nxtbook.com/ygsreprints/ILMA/G95397ILMA_vol65_no6
https://www.nxtbook.com/ygsreprints/ILMA/G94323ILMA_vol68_no5
https://www.nxtbook.com/ygsreprints/ILMA/G93127_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/G91785_ILMA_vol68_no3
https://www.nxtbook.com/ygsreprints/ILMA/G90956_ILMA_vol68_no2
https://www.nxtbook.com/ygsreprints/ILMA/G89146_ILMA_vol68_no1
https://www.nxtbook.com/ygsreprints/ILMA/G87981_ILMA_vol67_no12
https://www.nxtbook.com/ygsreprints/ILMA/G85409_ILMA_vol67_no11
https://www.nxtbook.com/ygsreprints/ILMA/G83595_ILMA_vol67_no10
https://www.nxtbook.com/ygsreprints/ILMA/G81672_ILMA_vol67_no9
https://www.nxtbook.com/ygsreprints/ILMA/G80238_ILMA_vol7_no8
https://www.nxtbook.com/ygsreprints/ILMA/G79388_ILMA_vol7_no7
https://www.nxtbook.com/ygsreprints/ILMA/G78361_ILMA_vol7_no6
https://www.nxtbook.com/ygsreprints/ILMA/G77448_ILMA_vol7_no5
https://www.nxtbook.com/ygsreprints/ILMA/G75899_ILMA_vol67_no4
https://www.nxtbook.com/ygsreprints/ILMA/G75036_ILMA_vol67_no3
https://www.nxtbook.com/ygsreprints/ILMA/G72720_ILMA_vol67_no2
https://www.nxtbook.com/ygsreprints/ILMA/G72220_ILMA_vol67_no1
https://www.nxtbook.com/ygsreprints/ILMA/G70970_ILMA_vol66_no12
https://www.nxtbook.com/ygsreprints/ILMA/G69813_ILMA_vol66_no11
https://www.nxtbook.com/ygsreprints/ILMA/G67522_ILMA_vol66_no10
https://www.nxtbook.com/ygsreprints/ILMA/G66343_ILMA_vol66_no9
https://www.nxtbook.com/ygsreprints/ILMA/G64859_ILMA_vol66_no8
https://www.nxtbookmedia.com